Lnterleukin-1α upregulates the expression of surfactant protein-a in rabbit lung explants

Neonatology

Volumn 71, Issue 1, 1997, Pages 46-52

  Dhar, Vijay ^a   Hallman, Mikko ^a   Lappalainen, Urpo ^b   Bry, Kristina ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

Chorioamnionitis; Cytokine; Lung development; Preterm labor; Surfactant protein B

Indexed keywords

BUCLADESINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; SURFACTANT;

AMNION FLUID; ANIMAL TISSUE; ARTICLE; FETUS; FETUS LUNG; LUNG DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMALS; BUCLADESINE; FEMALE; GENE EXPRESSION REGULATION; INTERLEUKIN-1; LUNG; ORGAN CULTURE TECHNIQUES; PREGNANCY; PROTEOLIPIDS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; PULMONARY SURFACTANT-ASSOCIATED PROTEINS; PULMONARY SURFACTANTS; RABBITS; RNA, MESSENGER;

EID: 0031018097     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000244396     Document Type: Article

References (42)

1. Clements JA, King RJ: Composition of surface-active material; in Crystal RG (ed): Biochemical Basis of Pulmonary Function, New York, Marcel Dekkcr, 1976. vol 2. pp 363-387.
2. Hawgood S, Benson BJ, Hamilton RL: Effects of surfactant-associated protein and calcium ions on the structure and surface activity oflung surfactant phospholipids, Biochemistry 1985;24:184-190.
3. Rice WR, Ross GF, Singleton M, Dingle S, Whitsett JA: Surfactant-associated protein inhibits phospholipid secretion from type 11 cells, J Appl Physiol 1987;63:692-698.
4. Geertsma MF, Nibberign PH, Haagsman HP, Daha MR, van Furth R: Binding of surfactant protein A to Clq receptors mediates phagocytosis of Staphylococcus aureus by monocytes, Am J Physiol 1994;267:L578-L584.
5. Wright JR, Youmans DC: Pulmonary surfactant protein A stimulates chemotaxis of alveolar macrophage, Am J Physiol 1993;264:L338-L344.
6. Hawgood S, Clements JA: Pulmonary surfactant and its apoproteins, J Clin Invest 1990;86:1-6.
7. Farrell PM, Avery MA: Hyaline membrane disease, Am Rev Rcspir Dis 1975:11 1:657-688.
8. Hallman M, Spragg R, Harrell JH, Moser KM, Gluck L: Evidence of lung surfactant abnormality in respiratory failure: Study of bronchoal-veolar lavage phospholipids, surface activity, phospholipase activity and plasma myoinositol, J Clin Invest 1982;70:673-683.
9. Dinarello CA, Wolff SM : Therolcof interleukin-1 in disease, N Engl J Med 1993;328:106-113.
10. Arend WP: Interleukin-1 receptor antagonist: A new member of the interleukin 1 family, J Clin Invest 1991:88:1445-1451.
11. Gibbs RS, Romero R, Hillier SL, Eschcnbach DA, Sweet RL: A review of premature birth and subclin-ical infection, Am J Obstct Gynecol 1992:166:1515-1528.
12. Romero R, Mazor M, Brandt F, Sepulveda W, Avila C, Cotton DB, Di-narcllo CA: Intcrlcukin-1 alpha and interleukin-1 beta in preterm and term human parturition, Am J Re-prod Immunol 1992:27:117-123.
13. Bry K, Hallman M: Injection of in-terleukin-la into the amniotic fluid increases the expression of surfactant proteins in fetal rabbit lungs, PediatrRes 1995;37:327A
14. Snyder JM, Mendclson CR, Johnston JM: The effect of cortisol on rabbit fetal lung maturation in vitro, Dev Biol 1981;85:129-140.
15. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction, Anal Bio-chem 1987;162:156-159.
16. Whitsett JA, Pilot T, Clark JC, Weaver TE: Induction of surfactant protein in fetal lung, Effects of cAMP and dcxamcthasonc on SAP-35 RNA and synthesis, J Biol Chem 1987;262:5256-5261.
17. Odom MJ, Snyder JM, Mendclson CR: Adenosine 3',5'-monophos-phate analogs and (i-adrencrgic agonists induce the synthesis of the major surfactant apoprotein in human fetal lung in vitro, Endocrinology 1987;121:1 155-1163.
18. Renkonen R, Mattila P, Hayry P, Ustinov J: Interleukin 1-induccd lymphocyte binding to endothelial cells: Role of cAMP as a second messenger, Eur J Immunol 1990:20: 1563-1567.
19. Ray K, Thompson N, Kennard N, Rollins P, Grenfell S, Withant S, Smithers N, Solari R: Investigation of guanine-nucleotidc-binding protein involvement and regulation of cyclic AMP metabolism in interleukin 1 signal transduction, Biochcm J 1992;282:59-67.
20. Nolte A, Bechtner G, Rafferzeder M, Gartner R: Interleukin-1 beta (IL-1 beta) binds to intact porcine thyroid follicles, decreases iodide uptake but has no effect on cAMP formation or proliferation, Horm Metab Res 1994:26:413-418.
21. Cadman ED, Naugles DD, Lee CM: cAMP is not involved in interleukin-1-induccd intcrleukin-6 release from human astrocytoma cells, Neu-rosci Lett 1994;178:251-254.
22. Green IC, Delaney CA, Cunningham JM, Karmiris V, Southern C: Interleukin-1 beta effects on cyclic GMP and cAMP in cultured rat islets of Langcrhans-arginine-depen-dence and relationship to insulin secretion, Diabctologia 1993:36:9-16.
23. Bomsztyk K, Toivola B, Emery DW, Rooney JW, Dower SK, Rachic NA, Sibley CH: Role of cAMP in interleukin-1-induced kappa light chain gene expression in murine B cell line, J Biol Chem 1990; 165:9413- 9417.
24. Pfcilschiftcr J, Leighton J, Pignat W, Marki F, Vosbeck K: Cyclic AMP mimics, but does not mediate, interleukin-1- and tumour necrosis factor-stimulated phospholipase A, secretion from rat renal mesangial cells, Biochcm J 1991:273:199-204.
25. Kassis S, Prabdakar U, Lee JC: Inhibition of interleukin-1 (IL-1) and tumor necrosis factor (TNF) production by pyridiny! imidazole compounds is independent of cAMP elevating mechanisms, Agents Actions 1993:39:C64-C66.
26. Gwosdow AR, O'Connell NA, Abou-Samra AB: lnterleukin-1 increases protein kinase A activity by acAMP-independent mechanism in AtT-10 cells, Am J Physiol 1994; 266:E79-E84.
27. Zitnik RJ, Zheng T, Elias JA: cAMP inhibition of interleukin-1-induced interleukin-6 production by human lung fibroblasts, Am J Physiol 1993; 64:L253-L260.
28. Mendclson CR, Acarrcgui MJ, Odom MJ, Boggaram V: Developmental and hormonal regulation of surfactant protein A (SP-A) gene expression in fetal lung, J Dev Physiol 1991;15:61-69.
29. Acarrcgui MJ, Snyder JM, Mitchell MD, Mendelson CR: Prostaglandins regulated surfactant protein A (SP-A) gene expression in human fetal lung in vitro, Endocrinology 1990:127:1105-1113.
30. Wispc JR, Clark JC, Warner BB, Fajardo D, Hull WE, Holtsman RB, Whitsell JA: Tumor necrosis factor-alplia inhibits expression of pulmonary surfactant protein, J Clin Invest 1990:86:1954-1960.
31. Dulkcrian SJ, Ballard PL: Effect of inflammatory mediators on surfactant proteins A and B, Pediatr Res 1994:35:296A
32. Ng SB, Tan YH, Guy GR: Differential induction of the interleukin-6 gene by tumor necrosis factor and interleukin-1. J Biol Chem 1994; 269:19021-19027.
33. Memon RA, Feingold KR, Moser AH, Doerrler W, Adi S, Dinarello CA, Grunfcld C: Differential effects of interleukin-1 and tumor necrosis factor on ketogenesis, Am J Physiol 1992:263:E301-E309.
34. Odom MJ, Snyder JM, Boggaram V, Mendelson CR: Glucocorticoid regulation of the major surfactant-associated protein (SP-A) and its mRNA and of morphologic development of human fetal lung in vitro, Endocrinology 1988:123:1712-1720.
35. Boggaram V, Mendelson CR: Transcriptional regulation of the gene encoding the major surfactant protein (SP-A) in rabbit fetai lung, J Biol Chem 1988:263:19060-19065.
36. Xu J, Possmaycr F: Exposure of rabbit fetal lung to glucocorticoids in vitro does not enhance transcription of the gene encoding pulmonary surfactant-associated protcin-B (SP-B), Biochim Biophys Acta 1993:1169: 146-155.
37. Barna I, Acs Z, Bugovics G, Koenig JI: Effect of intcrlcukin-1 beta on plasma ACTH, beta-endorphin, and corticosterone levels in infant and prepubertal rats, Pediatr Res 1995; 37:714-719.
38. Krcmlev SG, Phelps DS: Surfactant protein A stimulation of inflammatory cytokine and immunoglobulin production, Am J Physiol 1994:267: L712-L719.
39. Antal JM, Divis LT, Erzurum SC, Wiedeman HP, Thomasscn MJ: Surfactant suppresses NF-kB activation in human monocytic cells, Am J Rcspir Cell Mol Biol 1996; 14:374- 379.
40. Gomez R, Ghezzi F, Romero R, Munoz H, Tolosa JE, Rojas I: Premature labor and intra-amniotic infection: Clinical aspects and role of the cytokines in diagnosis and pathophysiology, Clin Perinatol 1995;22:281-342.
41. Wattcrbcrg KL, Demers LM, Scott SM, Murphy S: Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops, Pediatrics 1996; 97:210-215.
42. Hallak M, Bottoms SF: Accelerated pulmonary maturation from preterm premature rupture of membranes: A myth, Am J Obstet Gynecol 1993;169:1045-1049.